Capital Fund Management S.A. Edwards Lifesciences Corp Put Options Transaction History

Capital Fund Management S.A.

$34.4 Billion
Q1 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $5.14 Million - $6.77 Million	-70,800 Reduced 30.46%	161,600 $15.4 Million
Q4 2023 Feb 14, 2024	BUY	$61.71 - $77.76 $5.76 Million - $7.26 Million	93,400 Added 67.19%	232,400 $17.7 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $7.91 Million - $10.7 Million	114,200 Added 460.48%	139,000 $9.63 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $3 Million - $3.48 Million	-36,900 Reduced 59.81%	24,800 $2.34 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $2.67 Million - $3.04 Million	36,000 Added 140.08%	61,700 $5.1 Million

Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $607,870 - $778,216	8,900 Added 52.98%	25,700 $1.92 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $535,405 - $697,385	6,500 Added 63.11%	16,800 $1.39 Billion
Q2 2022 Aug 12, 2022	SELL	$86.5 - $128.27 $2.99 Million - $4.44 Million	-34,600 Reduced 77.06%	10,300 $979,000
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $840,323 - $1.03 Million	7,900 Added 21.35%	44,900 $5.82 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $2.47 Million - $2.95 Million	24,000 Added 184.62%	37,000 $4.19 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $75,456 - $94,284	900 Added 7.44%	13,000 $1.35 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $64,521 - $82,107	900 Added 8.04%	12,100 $1.1 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $470,330 - $612,080	-7,000 Reduced 38.46%	11,200 $893,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $771,036 - $1.03 Million	13,400 Added 279.17%	18,200 $1.26 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $1.37 Million - $2.12 Million	-26,200 Reduced 84.52%	4,800 $301,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $1.13 Million - $1.3 Million	15,800 Added 103.95%	31,000 $7.23 Million
Q3 2019 Nov 13, 2019	BUY	$61.55 - $75.43 $418,540 - $512,924	6,800 Added 80.95%	15,200 $3.34 Million
Q2 2019 Aug 12, 2019	BUY	$55.74 - $64.41 $395,754 - $457,311	7,100 Added 546.15%	8,400 $1.55 Million
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $62,257 - $83,265	1,300 New	1,300 $249,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $1.2 Million - $1.52 Million	-26,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$42.45 - $51.3 $101,880 - $123,120	-2,400 Reduced 8.39%	26,200 $3.81 Million
Q1 2018 May 15, 2018	BUY	$37.19 - $47.45 $1.06 Million - $1.36 Million	28,600 New	28,600 $3.99 Million

Others Institutions Holding EW

# of Institutions

1,378

Shares Held

454M

Call Options Held

3.86M

Put Options Held

3.32M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $57.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account